vernakalant News
Most Popular vernakalant Story
Cardiome shares plunge after FDA red lights vernakalant Ph3
An unexpected case of cardiogenic shock forced investigators at Astellas to halt enrollment for a late-stage confirmatory study of the atrial fibrillation drug vernakalant. And while the monitoring Read more...
Latest Headlines
- July 27, 2011
- October 21, 2010
- September 2, 2010
- June 25, 2010
- August 11, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
